The global neurological biomarkers market is on track for remarkable growth, driven by the escalating demand for precise diagnostic tools and effective treatment monitoring solutions for neurological disorders. According to a recent market analysis, the sector is projected to achieve a Compound Annual Growth Rate (CAGR) of 4.6% over the forecast period, with the market value anticipated to reach USD 12.5 billion by 2033. In 2023, the market was valued at USD 8 billion, reflecting a significant upward trajectory.
Neurological biomarkers are crucial in the diagnosis and management of various neurological disorders, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. These biomarkers are at the forefront of advancements in precision medicine, which is fueling the growth of the neurological biomarkers market. The rising prevalence of neurological disorders globally underscores the need for innovative diagnostic methods and personalized treatment plans that can enhance patient outcomes.
Key Market Drivers:
- Rising Prevalence of Neurological Disorders: With the global increase in neurological conditions, there is a growing demand for early detection and personalized treatment, which neurological biomarkers can provide.
- Research and Development Investments: Substantial investments in R&D and collaborations between pharmaceutical companies and research institutions are driving the discovery of new biomarkers and the development of advanced diagnostic technologies.
- Regional Market Leaders: The U.S. is expected to account for a significant share of the global neurological biomarkers market, driven by its leading laboratories and scientists. Meanwhile, the Asia-Pacific region, particularly Japan and India, is predicted to hold the largest share, thanks to the launch of novel solutions and the development of methods that enable earlier diagnosis and improved prognoses.
Segment Highlights:
- Type: Genomic biomarkers are expected to dominate the market, with expanding R&D initiatives focused on producing personalized medications for neurological illnesses.
- Application: Alzheimer’s disease remains the most common neurological disorder, making it the most profitable application area for manufacturers.
- End User: Research organizations, pharma & biotech companies, and clinical diagnostics are the primary end users driving market demand.
Unlock Full Analysis: Find the Complete Report on Neurological Biomarkers Market Here
Competitive Landscape:
Key players in the neurological biomarkers market are focusing on product innovation and global expansion. Companies such as Quanterix, Qiagen, ADx NeuroSciences NV, Merck KGaA, and Thermo Fisher Scientific are actively engaged in launching new products and expanding their presence in emerging markets. These efforts are expected to significantly contribute to the market’s growth.
Recent Developments:
- In August 2020, Johnson & Johnson Services, Inc. partnered with Enigma Biomedical Group to evaluate novel neuroimaging biomarkers for Alzheimer’s disease and other dementias.
- In 2019, MC10 Inc. collaborated with the University of Rochester to develop novel digital biomarkers for central nervous system diseases.
Market Segmentation:
- By Type: Genomics Biomarkers, Proteomics Biomarkers, Metabolomics Biomarkers, Imaging Biomarkers, Others.
- By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy.
- By End User: Research Organizations, Pharma & Biotech Companies, Clinical Diagnostics.
- By Region: North America, Latin America, Asia Pacific, Middle East and Africa (MEA), Europe.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
